🇺🇸 FDA
Patent

US 6737045

Methods and compositions for the pulmonary delivery insulin

expired A61KA61K38/28A61K47/12

Quick answer

US patent 6737045 (Methods and compositions for the pulmonary delivery insulin) held by Nektar Therapeutics expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/28, A61K47/12, A61K47/183, A61K47/26